Exploratory data analysis, classification, comparative analysis, case severity detection, and internet of things in COVID-19 telemonitoring for smart hospitals

The proportion of COVID-19 patients is significantly expanding around the world. Treatment with serious consideration has become a significant problem. Identifying clinical indicators of succession towards severe conditions is desperately required to empower hazard stratification and optimise resource allocation in the pandemic of COVID-19. Consequently, the classification of severity level is significant for the patient's triaging. It is required to categorise the severity level as mild, moderate, severe, and critical based on the patients' symptoms. Various symptomatic parameters may encourage the evaluation of infection seriousness. Likewise, with the rapid spread and transmissibility of COVID-19 patients, it is crucial to utilise telemonitoring schemes for COVID-19 patients. Telemonitoring mediation encourages remote data and information exchange among medicinal services, suppliers, and patients, furthermore, risk mitigation and provision of appropriate medical facilities. This paper provides explorative data analysis of symptoms, comorbidities, and other parameters, comparing different machine learning algorithms for case severity detection. This paper also provides a system (based on the degree of truthfulness) for case severity detection that might be utilised to stratify risk levels for anticipated moderate and severe COVID-19 patients. Finally, we provide a telemonitoring model of COVID-19 patients to ensure the remote and continuous monitoring of case severity progression and appropriate risk mitigation strategies. [ FROM AUTHOR] Copyright of Journal of Experimental & Theoretical Artificial Intelligence is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

AI-MIA: COVID-19 Detection and Severity Analysis Through Medical Imaging

This paper presents the baseline approach for the organized 2nd Covid-19 Competition, occurring in the framework of the AIMIA Workshop in the European Conference on Computer Vision (ECCV 2022). It presents the COV19-CT-DB database which is annotated for COVID-19 detection, consisting of about 7,700 3-D CT scans. Part of the database consisting of Covid-19 cases is further annotated in terms of four Covid-19 severity conditions. We have split the database and the latter part of it in training, validation and test datasets. The former two datasets are used for training and validation of machine learning models, while the latter is used for evaluation of the developed models. The baseline approach consists of a deep learning approach, based on a CNN-RNN network and report its performance on the COVID19-CT-DB database. The paper presents the results of both Challenges organised in the framework of the Competition, also compared to the performance of the baseline scheme. © 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.

Boosting COVID-19 Severity Detection with Infection-Aware Contrastive Mixup Classification

This paper presents our solution for the 2nd COVID-19 Severity Detection Competition. This task aims to distinguish the Mild, Moderate, Severe, and Critical grades in COVID-19 chest CT images. In our approach, we devise a novel infection-aware 3D Contrastive Mixup Classification network for severity grading. Specifically, we train two segmentation networks to first extract the lung region and then the inner lesion region. The lesion segmentation mask serves as complementary information for the original CT slices. To relieve the issue of imbalanced data distribution, we further improve the advanced Contrastive Mixup Classification network by weighted cross-entropy loss. On the COVID-19 severity detection leaderboard, our approach won the first place with a Macro F1 Score of 51.76%. It significantly outperforms the baseline method by over 11.46%. © 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.

Severity detection of COVID-19 infection with machine learning of clinical records and CT images.

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a deadly viral infection spreading rapidly around the world since its outbreak in 2019. In the worst case a patient's organ may fail leading to death. Therefore, early diagnosis is crucial to provide patients with adequate and effective treatment. OBJECTIVE: This paper aims to build machine learning prediction models to automatically diagnose COVID-19 severity with clinical and computed tomography (CT) radiomics features. METHOD: P-V-Net was used to segment the lung parenchyma and then radiomics was used to extract CT radiomics features from the segmented lung parenchyma regions. Over-sampling, under-sampling, and a combination of over- and under-sampling methods were used to solve the data imbalance problem. RandomForest was used to screen out the optimal number of features. Eight different machine learning classification algorithms were used to analyze the data. RESULTS: The experimental results showed that the COVID-19 mild-severe prediction model trained with clinical and CT radiomics features had the best prediction results. The accuracy of the GBDT classifier was 0.931, the ROUAUC 0.942, and the AUCPRC 0.694, which indicated it was better than other classifiers. CONCLUSION: This study can help clinicians identify patients at risk of severe COVID-19 deterioration early on and provide some treatment for these patients as soon as possible. It can also assist physicians in prognostic efficacy assessment and decision making.

Severity Detection for the Coronavirus Disease 2019 (COVID-19) Patients Using a Machine Learning Model Based on the Blood and Urine Tests.

The recent outbreak of the coronavirus disease-2019 (COVID-19) caused serious challenges to the human society in China and across the world. COVID-19 induced pneumonia in human hosts and carried a highly inter-person contagiousness. The COVID-19 patients may carry severe symptoms, and some of them may even die of major organ failures. This study utilized the machine learning algorithms to build the COVID-19 severeness detection model. Support vector machine (SVM) demonstrated a promising detection accuracy after 32 features were detected to be significantly associated with the COVID-19 severeness. These 32 features were further screened for inter-feature redundancies. The final SVM model was trained using 28 features and achieved the overall accuracy 0.8148. This work may facilitate the risk estimation of whether the COVID-19 patients would develop the severe symptoms. The 28 COVID-19 severeness associated biomarkers may also be investigated for their underlining mechanisms how they were involved in the COVID-19 infections.